Key Therap

Key Therapeutics is a specialty pharmaceutical company based in Flowood, Mississippi, focused on the acquisition, commercialization, and distribution of mature, approved pharmaceutical products and niche generic formulations. The company maintains a diverse portfolio of brands across therapeutic areas such as urology, pediatrics, women's health, and infectious diseases. Key Therapeutics expanded its portfolio through the acquisition of assets from Xspire Pharma and Wraser Pharmaceuticals, as well as the purchase of established brands like Desoxyn and Cetraxal. The company is privately held and backed by private equity investors, including Plexus Capital and HealthEdge Investment Partners. Its business model centers on revitalizing under-performing assets through targeted marketing and efficient distribution channels. Key Therapeutics operates as a commercial-stage entity with a focus on the North American market.